AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
companies in this sector in the United States:
sales of $20.85 billion
of which 33%
Teva Pharmaceutical Industries Limited
of which 55%
was Generic Madicines), and
Eli Lilly and Company
of which 38%
During the year ended December of 2016, sales at
AstraZeneca PLC were $23.00 billion.
decrease of 6.9%
versus 2015, when the company's sales were $24.71 billion.